First Time Loading...

Gland Pharma Ltd
NSE:GLAND

Watchlist Manager
Gland Pharma Ltd Logo
Gland Pharma Ltd
NSE:GLAND
Watchlist
Price: 1 710 INR 1% Market Closed
Updated: May 11, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

49.1B
+14%
Revenue
Growth Rates:
1 Year
+25%
3 Years
-6%
5 Years
-
7 Years
-
10 Years
-
8.5B
-0.1%
Operating Income
Growth Rates:
1 Year
-20%
3 Years
-52%
5 Years
-
7 Years
-
10 Years
-
6.6B
-6%
Net Income
Growth Rates:
1 Year
-33%
3 Years
-56%
5 Years
-
7 Years
-
10 Years
-

Earnings Waterfall
Gland Pharma Ltd

Revenue
49.1B INR
Cost of Revenue
-19.4B INR
Gross Profit
29.7B INR
Operating Expenses
-21.2B INR
Operating Income
8.5B INR
Other Expenses
-1.9B INR
Net Income
6.6B INR

Income Statement
Gland Pharma Ltd

Rotate your device to view
Income Statement
Currency: INR
Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
41 634
N/A
49 949
+20%
52 084
+4%
34 629
-34%
37 326
+8%
39 815
+7%
41 854
+5%
44 007
+5%
41 037
-7%
40 676
-1%
39 426
-3%
36 246
-8%
39 764
+10%
43 054
+8%
49 123
+14%
Gross Profit
Cost of Revenue
(17 452)
(21 187)
(22 481)
(15 382)
(17 084)
(18 589)
(19 555)
(21 493)
(19 468)
(19 422)
(18 659)
(17 333)
(17 643)
(17 664)
(19 385)
Gross Profit
24 182
N/A
28 762
+19%
29 603
+3%
19 247
-35%
20 242
+5%
21 226
+5%
22 300
+5%
22 514
+1%
21 569
-4%
21 254
-1%
20 767
-2%
18 913
-9%
22 121
+17%
25 390
+15%
29 737
+17%
Operating Income
Operating Expenses
(9 814)
(11 664)
(11 987)
(7 213)
(7 981)
(8 191)
(8 446)
(8 513)
(9 327)
(9 915)
(10 119)
(10 068)
(13 405)
(16 848)
(21 204)
Selling, General & Administrative
(7 347)
(8 325)
(8 468)
(5 902)
(3 996)
(4 077)
(4 118)
(6 946)
(4 628)
(4 903)
(5 150)
(8 100)
(7 008)
(9 307)
(12 097)
Research & Development
(296)
0
0
(322)
0
0
0
(427)
0
0
0
(404)
0
0
0
Depreciation & Amortization
(1 430)
(1 677)
(1 684)
(988)
(998)
(1 013)
(1 041)
(1 103)
(1 199)
(1 305)
(1 403)
(1 467)
(1 771)
(2 218)
(2 895)
Other Operating Expenses
(740)
(1 662)
(1 834)
(1)
(2 986)
(3 101)
(3 287)
(38)
(3 500)
(3 707)
(3 566)
(97)
(4 625)
(5 323)
(6 212)
Operating Income
14 368
N/A
17 099
+19%
17 616
+3%
12 034
-32%
12 261
+2%
13 035
+6%
13 853
+6%
14 000
+1%
12 242
-13%
11 339
-7%
10 648
-6%
8 844
-17%
8 717
-1%
8 543
-2%
8 533
0%
Pre-Tax Income
Interest Income Expense
1 377
1 370
1 415
1 236
(19)
(22)
(22)
2 189
(51)
(58)
(73)
2 331
(115)
(158)
(184)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
(628)
(565)
(565)
(565)
Gain/Loss on Disposition of Assets
174
0
0
0
0
0
0
(2)
0
0
0
(1)
0
0
0
Total Other Income
281
658
757
78
1 625
1 933
2 039
(2)
2 364
2 508
2 667
(1)
2 036
1 911
1 670
Pre-Tax Income
16 200
N/A
19 126
+18%
19 787
+3%
13 348
-33%
13 867
+4%
14 947
+8%
15 870
+6%
16 186
+2%
14 555
-10%
13 789
-5%
13 242
-4%
10 546
-20%
10 073
-4%
9 732
-3%
9 455
-3%
Net Income
Tax Provision
(3 795)
(4 532)
(4 693)
(3 378)
(3 526)
(3 774)
(4 008)
(4 069)
(3 650)
(3 493)
(3 357)
(2 735)
(2 614)
(2 743)
(2 867)
Income from Continuing Operations
12 405
14 594
15 094
9 970
10 340
11 173
11 862
12 117
10 905
10 296
9 885
7 810
7 460
6 988
6 587
Net Income (Common)
12 405
N/A
14 594
+18%
15 094
+3%
9 970
-34%
7 736
-22%
8 568
+11%
9 258
+8%
12 117
+31%
10 905
-10%
10 296
-6%
9 885
-4%
7 810
-21%
7 460
-4%
6 988
-6%
6 587
-6%
EPS (Diluted)
75.96
N/A
94.15
+24%
94.81
+1%
62.99
-34%
47.14
-25%
52.1
+11%
56.35
+8%
73.64
+31%
66.24
-10%
62.52
-6%
60
-4%
47.43
-21%
45.28
-5%
42.41
-6%
39.98
-6%

See Also

Summary
GLAND intrinsic value, competitors valuation, and company profile.
DCF Valuation
GLAND stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GLAND stock valuation using valuation multiples.
Wall Street Estimates
GLAND price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GLAND stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.